跳至主要内容
临床试验/NCT02253095
NCT02253095已完成不适用

Randomized, Double Blind, Placebo Controlled Trial Comparing the Impact of a Combined Package of Interventions vs Placebo in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 253 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
253
试验地点
1
主要终点
Dual Sugar Absorption Test

研究概览

简要总结

Randomized, double-blind, placebo controlled trial of a combined intervention of zinc, albendazole, and multiple micronutrients in improving environmental enteropathy in Malawian children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Months 至 35 Months(Child)
性别
All
接受健康志愿者

入选标准

  • children residing in catchment area of Limela, Machinga District, Malawi
  • aged 12-35 months
  • youngest eligible child in each household

排除标准

  • severe acute malnutrition
  • severe chronic illness
  • children unable to drink 20 mL of dual sugar solution
  • children in need of acute medical treatment for illness or injury at time of enrollment

研究组 & 干预措施

Multiple Intervention Arm

Experimental

single dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients

干预措施: Albendazole (Drug)

Multiple Intervention Arm

Experimental

single dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients

干预措施: Zinc (Dietary Supplement)

Multiple Intervention Arm

Experimental

single dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients

干预措施: Multiple Micronutrient Supplement (Dietary Supplement)

Placebo

Placebo Comparator

three placebos

干预措施: Placebo (Drug)

结局指标

主要结局

Dual Sugar Absorption Test

时间窗: 24 weeks

lactulose-mannitol ratio in urine

次要结局

  • Lactulose Excretion(24 weeks)
  • Mannitol Excretion(24 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验